Newmont Mining CorporationNEM has been performing well of late. The company has a market capitalization of roughly $20.5 billion. The stock has moved up 18% over the past six months, outperforming the industry 's 7.9% growth. With strong fundamentals and solid long-term growth opportunities, this stock can be a solid bet now.
Upbeat FY18 & Long-Term Outlook
Newmont has revised its outlook for 2018. The company's updated outlook reflects ongoing investment in its operating assets and promising growth prospects along with stable gold production.
The company increased attributable gold production guidance for 2018 to a range of 4.9-5.4 million ounces (up from 4.7-5.2 million ounces expected earlier), primarily driven by its Full Potential mine plan, recovery and throughput improvements. The company expects production in the range of 4.9-5.4 million ounces in 2019 and long-term production is projected to remain stable in the range of 4.6-5.1 million ounces per annum through 2022.
Newmont expects all-in sustaining costs (AISC) to be between $965 per ounce and $1,025 per ounce for 2018, compared with its earlier guidance of $950-$1,050. The company expects AISC in the range of $870-$970 per ounce in 2019 and long-term through 2022.
Costs applicable to sales (CAS) is now expected to be the range of $700-$750 per ounce in 2018, compared with prior guidance of $700-$800, factoring in an increase in production in North America and Africa, and Full Potential efficiency and cost improvements across the portfolio. CAS is expected to range $620-$720 per ounce for 2019 and $650-$750 over the long-term through 2022.
Targets Dividend Hike
Based on improved outlook and portfolio and balance sheet improvements, Newmont aims to increase its dividend by at least 50% in 2018. Moreover, the company expects to continue investing in margin and reserve growth and deliver a steady gold production at competitive costs over the next five years.
Growth Projects & Debt-Reduction Bode Well
Newmont is making notable progress with its growth projects, including Tanami Expansion in Australia, and Subika Underground and Ahafo mill expansion in Africa.
Recently, the company has landed a deal to further explore the potential Esperance gold discovery in French Guiana, owned by Compagnie Miniere Esperance. The deal enables Newmont to earn up to a 70% interest in the property through multi-year investments.
Notably, Newmont increased its advanced and exploration projects investments by roughly 25% last year, roughly two-thirds of which will be used to fund more greenfields and brownfields exploration.
The company also remains committed to deleverage its balance sheet and has lowered net debt to $1.1 billion at the end of third-quarter 2017.
Earnings Surprise History
Newmont has outpaced the Zacks Consensus Estimate in three of the trailing four quarters with a positive average earnings surprise of 17.6%.
Newmont Mining Corporation Price and Consensus
Zacks Rank & Other Key Picks
Newmont currently sports a Zacks Rank #1 (Strong Buy).
A few other top-ranked stocks in the basic materials space are Huntsman Corporation HUN , Daqo New Energy Corp. DQ and Kronos Worldwide Inc. KRO , each flaunting a Zacks Rank #1. You can see the complete list of today's Zacks #1 Rank stocks here .
Huntsman has an expected long-term earnings growth rate of 8%. Its shares have soared 80.7% over a year.
Daqo New Energy has an expected long-term earnings growth rate of 7%. Its shares have rallied a whopping 214.3% over a year.
Kronos Worldwide has an expected long-term earnings growth rate of 5%. Its shares have surged 112.4% over a year.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.